Works by Choon Hee Chung

Results: 82
    1
    2
    3
    4
    5
    6
    7

    Combined use of basal insulin analog and acarbose reduces postprandial glucose in patients with uncontrolled type 2 diabetes.

    Published in:
    Journal of Diabetes Investigation, 2015, v. 6, n. 2, p. 219, doi. 10.1111/jdi.12261
    By:
    • Kim, Ji‐Hyun;
    • Ahn, Ji‐Hyun;
    • Kim, Soo‐Kyung;
    • Lee, Dae‐Ho;
    • Kim, Hye‐Soon;
    • Shon, Ho‐Sang;
    • Jeon, Hyun‐Jeong;
    • Kim, Tae‐Hwa;
    • Cho, Yong‐Wook;
    • Kim, Jae‐Taek;
    • Han, Sung‐Min;
    • Chung, Choon‐Hee;
    • Ryu, Ohk‐Hyun;
    • Lee, Jae‐Min;
    • Lee, Soon‐Hee;
    • Kwon, Min‐Jeong;
    • Kim, Tae‐kyun;
    • Namgoong, Il‐Seong;
    • Kim, Eun‐Sook;
    • Jung, In‐Kyung
    Publication type:
    Article
    8

    Efficacy of glimepiride/metformin fixed-dose combination vs metformin uptitration in type 2 diabetic patients inadequately controlled on low-dose metformin monotherapy: A randomized, open label, parallel group, multicenter study in Korea.

    Published in:
    Journal of Diabetes Investigation, 2014, v. 5, n. 6, p. 701, doi. 10.1111/jdi.12201
    By:
    • Kim, Hye‐soon;
    • Kim, Doo‐man;
    • Cha, Bong‐soo;
    • Park, Tae Sun;
    • Kim, Kyoung‐ah;
    • Kim, Dong‐lim;
    • Chung, Choon Hee;
    • Park, Jeong‐hyun;
    • Jang, Hak Chul;
    • Choi, Dong‐seop
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15

    Rice bran protein hydrolysates attenuate diabetic nephropathy in diabetic animal model.

    Published in:
    European Journal of Nutrition, 2018, v. 57, n. 2, p. 761, doi. 10.1007/s00394-016-1366-y
    By:
    • Boonloh, Kampeebhorn;
    • Lee, Eun Soo;
    • Kim, Hong Min;
    • Kwon, Mi Hye;
    • Kim, You Mi;
    • Pannangpetch, Patchareewan;
    • Kongyingyoes, Bunkerd;
    • Kukongviriyapan, Upa;
    • Thawornchinsombut, Supawan;
    • Lee, Eun Young;
    • Kukongviriyapan, Veerapol;
    • Chung, Choon Hee
    Publication type:
    Article
    16
    17

    A randomized, placebo-controlled, double-blind, phase 3 trial to evaluate the efficacy and safety of anagliptin in drug-naïve patients with type 2 diabetes.

    Published in:
    Endocrine Journal, 2015, v. 62, n. 5, p. 449, doi. 10.1507/endocrj.ej14-0544
    By:
    • Hae Kyung Yang;
    • Kyung Wan Min;
    • Sung Woo Park;
    • Choon Hee Chung;
    • Kyong Soo Park;
    • Sung Hee Choi;
    • Ki-Ho Song;
    • Doo-Man Kim;
    • Moon-Kyu Lee;
    • Yeon-Ah Sung;
    • Sei Hyun Baik;
    • In Joo Kim;
    • Bong-Soo Cha;
    • Jeong Hyun Park;
    • Yu Bae Ahn;
    • In-Kyu Lee;
    • Soon Jib Yoo;
    • Jaetaek Kim;
    • Ie Byung Park;
    • Tae Sun Park
    Publication type:
    Article
    18

    The myokine meteorin‐like (metrnl) improves glucose tolerance in both skeletal muscle cells and mice by targeting AMPKα2.

    Published in:
    FEBS Journal, 2020, v. 287, n. 10, p. 2087, doi. 10.1111/febs.15301
    By:
    • Lee, Jung Ok;
    • Byun, Won Seok;
    • Kang, Min Ju;
    • Han, Jeong Ah;
    • Moon, Jiyoung;
    • Shin, Min‐Jeong;
    • Lee, Ho Jun;
    • Chung, Ji Hyung;
    • Lee, Jin‐Seok;
    • Son, Chang‐Gue;
    • Song, Kwon‐Ho;
    • Kim, Tae Woo;
    • Lee, Eun‐Soo;
    • Kim, Hong Min;
    • Chung, Choon Hee;
    • Ngoei, Kevin R. W.;
    • Ling, Naomi X. Y.;
    • Oakhill, Jonathan S.;
    • Galic, Sandra;
    • Murray‐Segal, Lisa
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28

    Basal-prandial versus premixed insulin in patients with type 2 diabetes requiring insulin intensification after basal insulin optimization: A 24-week randomized non-inferiority trial 接受基础胰岛素优化治疗之后需要胰岛素强化治疗的患者使用基础-餐时胰岛素治疗与使用预混胰岛素治疗的对照试验:一项为期24周的随机非劣性试验

    Published in:
    Journal of Diabetes, 2016, v. 8, n. 3, p. 405, doi. 10.1111/1753-0407.12312
    By:
    • Jin, Sang ‐ Man;
    • Kim, Jae Hyeon;
    • Min, Kyung Wan;
    • Lee, Ji Hyun;
    • Ahn, Kue Jeong;
    • Park, Jeong Hyun;
    • Jang, Hak Chul;
    • Park, Seok Won;
    • Lee, Kwan Woo;
    • Won, Kyu Chang;
    • Kim, Young ‐ Il;
    • Chung, Choon Hee;
    • Park, Tae Sun;
    • Lee, Jee ‐ Hyun;
    • Lee, Moon ‐ Kyu
    Publication type:
    Article
    29

    EPRS1-mediated fibroblast activation and mitochondrial dysfunction promote kidney fibrosis.

    Published in:
    Experimental & Molecular Medicine EMM, 2024, v. 56, n. 12, p. 2673, doi. 10.1038/s12276-024-01360-6
    By:
    • Son, Seung Seob;
    • Jeong, Hee Seul;
    • Lee, Seong-Woo;
    • Lee, Eun Soo;
    • Lee, Jeong Geon;
    • Lee, Ji-Hye;
    • Yi, Jawoon;
    • Park, Mi Ju;
    • Choi, Min Sun;
    • Lee, Donghyeong;
    • Choi, Sin Young;
    • Ha, Jiheon;
    • Kang, Jeong Suk;
    • Cho, Nam-Jun;
    • Park, Samel;
    • Gil, Hyo-Wook;
    • Chung, Choon Hee;
    • Park, Joon Seok;
    • Kim, Myung Hee;
    • Park, Jihwan
    Publication type:
    Article
    30
    31
    32

    Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus.

    Published in:
    Clinical Endocrinology, 2007, v. 66, n. 2, p. 282, doi. 10.1111/j.1365-2265.2006.02723.x
    By:
    • Kim, Hyeong Jin;
    • Kang, Eun Seok;
    • Kim, Dae Jung;
    • Kim, So Hun;
    • Ahn, Chul Woo;
    • Cha, Bong Soo;
    • Nam, Moonsuk;
    • Chung, Choon Hee;
    • Lee, Kwan Woo;
    • Nam, Chung Mo;
    • Lee, Hyun Chul
    Publication type:
    Article
    33

    Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate- Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk Factors (ENSEMBLE).

    Published in:
    Endocrinology & Metabolism, 2024, v. 39, n. 5, p. 722, doi. 10.3803/EnM.2024.1995
    By:
    • Nam Hoon Kim;
    • Juneyoung Lee;
    • Suk Chon;
    • Jae Myung Yu;
    • In-Kyung Jeong;
    • Soo Lim;
    • Won Jun Kim;
    • Keeho Song;
    • Ho Chan Cho;
    • Hea Min Yu;
    • Kyoung-Ah Kim;
    • Sang Soo Kim;
    • Soon Hee Lee;
    • Chong Hwa Kim;
    • Soo Heon Kwak;
    • Yong‐ho Lee;
    • Choon Hee Chung;
    • Sihoon Lee;
    • Heung Yong Jin;
    • Jae Hyuk Lee
    Publication type:
    Article
    34
    35
    36
    37

    Metabolic Subtyping of Adrenal Tumors: Prospective Multi-Center Cohort Study in Korea.

    Published in:
    Endocrinology & Metabolism, 2021, v. 36, n. 5, p. 1131, doi. 10.3803/EnM.2021.1149
    By:
    • Eu Jeong Ku;
    • Chaelin Lee;
    • Jaeyoon Shim;
    • Sihoon Lee;
    • Kyoung-Ah Kim;
    • Sang Wan Kim;
    • Yumie Rhee;
    • Hyo-Jeong Kim;
    • Jung Soo Lim;
    • Choon Hee Chung;
    • Sung Wan Chun;
    • Soon-Jib Yoo;
    • Ohk-Hyun Ryu;
    • Ho Chan Cho;
    • A Ram Hong;
    • Chang Ho Ahn;
    • Jung Hee Kim;
    • Man Ho Choi
    Publication type:
    Article
    38
    39

    Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetes Mellitus: A Review and Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association.

    Published in:
    Diabetes & Metabolism Journal, 2024, v. 48, n. 6, p. 1015, doi. 10.4093/dmj.2024.0541
    By:
    • Jaehyun Bae;
    • Eugene Han;
    • Hye Won Lee;
    • Cheol-Young Park;
    • Choon Hee Chung;
    • Dae Ho Lee;
    • Eun-Hee Cho;
    • Eun-Jung Rhee;
    • Ji Hee Yu;
    • Ji Hyun Park;
    • Ji-Cheol Bae;
    • Jung Hwan Park;
    • Kyung Mook Choi;
    • Kyung-Soo Kim;
    • Mi Hae Seo;
    • Minyoung Lee;
    • Nan-Hee Kim;
    • So Hun Kim;
    • Won-Young Lee;
    • Woo Je Lee
    Publication type:
    Article
    40

    Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial.

    Published in:
    Diabetes & Metabolism Journal, 2024, v. 48, n. 4, p. 730, doi. 10.4093/dmj.2023.0077
    By:
    • Jie-Eun Lee;
    • Seung Hee Yu;
    • Sung Rae Kim;
    • Kyu Jeung Ahn;
    • Kee-Ho Song;
    • In-Kyu Lee;
    • Ho-Sang Shon;
    • In Joo Kim;
    • Soo Lim;
    • Doo-Man Kim;
    • Choon Hee Chung;
    • Won-Young Lee;
    • Soon Hee Lee;
    • Dong Joon Kim;
    • Sung-Rae Cho;
    • Chang Hee Jung;
    • Hyun Jeong Jeon;
    • Seung-Hwan Lee;
    • Keun-Young Park;
    • Sang Youl Rhee
    Publication type:
    Article
    41
    42

    Efficacy and Safety of Evogliptin Add-on Therapy to Dapagliflozin/Metformin Combinations in Patients with Poorly Controlled Type 2 Diabetes Mellitus: A 24-Week Multicenter Randomized Placebo-Controlled Parallel-Design Phase-3 Trial with a 28-Week Extension

    Published in:
    Diabetes & Metabolism Journal, 2023, v. 47, n. 6, p. 808, doi. 10.4093/dmj.2022.0387
    By:
    • Jun Sung Moon;
    • Il Rae Park;
    • Hae Jin Kim;
    • Choon Hee Chung;
    • Kyu Chang Won;
    • Kyung Ah Han;
    • Cheol-Young Park;
    • Jong Chul Won;
    • Dong Jun Kim;
    • Gwan Pyo Koh;
    • Eun Sook Kim;
    • Jae Myung Yu;
    • Eun-Gyoung Hong;
    • Chang Beom Lee;
    • Kun-Ho Yoon
    Publication type:
    Article
    43
    44
    45
    46
    47
    48

    A randomized, double-blind, placebo-controlled, phase II clinical trial to investigate the efficacy and safety of oral DA-1229 in patients with type 2 diabetes mellitus who have inadequate glycaemic control with diet and exercise.

    Published in:
    Diabetes/Metabolism Research & Reviews, 2015, v. 31, n. 3, p. 295, doi. 10.1002/dmrr.2613
    By:
    • Jung, Chang Hee;
    • Park, Cheol‐Young;
    • Ahn, Kyu‐Joeng;
    • Kim, Nan‐Hee;
    • Jang, Hak‐Chul;
    • Lee, Moon‐Kyu;
    • Park, Joong‐Yeol;
    • Chung, Choon‐Hee;
    • Min, Kyung‐Wan;
    • Sung, Yeon‐Ah;
    • Park, Jeong‐Hyun;
    • Kim, Sung Jin;
    • Lee, Hyo Jung;
    • Park, Sung‐Woo
    Publication type:
    Article
    49
    50